2373 — Beauty Farm Medical & Health Industry Balance Sheet
0.000.00%
Last trade - 00:00- HK$4.50bn
- HK$3.11bn
- CNY3.00bn
Annual balance sheet for Beauty Farm Medical & Health Industry, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,084 | 911 | 1,574 | 1,831 | 2,542 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 47.5 | 71.9 | 91.3 | 74.8 | 85.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,309 | 1,248 | 1,936 | 2,186 | 2,858 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 711 | 789 | 887 | 900 | 810 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,477 | 2,495 | 3,302 | 4,276 | 5,046 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,854 | 1,909 | 2,052 | 2,739 | 2,910 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 2,220 | 2,307 | 2,500 | 3,332 | 4,024 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 257 | 189 | 802 | 945 | 1,022 |
| Total Liabilities & Shareholders' Equity | 2,477 | 2,495 | 3,302 | 4,276 | 5,046 |
| Total Common Shares Outstanding |